论文部分内容阅读
目的:本文探讨胰岛素早期分泌改善治疗对糖耐量减低的干预疗效。方法:对60例糖耐量减低患者随机分组,进行饮食、运动或瑞格列奈干预治疗。结果:对照组(饮食、运动组)血糖、胰岛素轻度下降,无统计学差异(P>0.05);治疗组(小剂量瑞格列奈组)血糖、胰岛素显著下降(P<0.05),有统计学意义。结论:小剂量瑞格列奈能改善糖耐量减低患者的糖耐量,使其恢复正常糖耐量状态。
Objective: This article discusses the early insulin secretion improved treatment of impaired glucose tolerance intervention effect. Methods: Sixty patients with impaired glucose tolerance were randomly assigned to diet, exercise or repaglinide treatment. Results: The blood glucose and insulin in the control group (diet, exercise group) decreased slightly, with no significant difference (P> 0.05). The blood glucose and insulin in the low-dose repaglinide group were significantly decreased Statistical significance. CONCLUSIONS: A low-dose repaglinide improves glucose tolerance in patients with impaired glucose tolerance and returns to normal glucose tolerance.